Hormone Replacement Therapy (HRT) for Men Comprehensive Panel
This comprehensive men’s HRT blood test panel checks testosterone, estradiol, SHBG, CBC, CMP, lipids, PSA and more to guide dosing and safety.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a comprehensive lab panel designed for men who are considering testosterone therapy or already using TRT/HRT and want your hormone levels and key safety markers interpreted as one story. Instead of chasing single numbers, you get a grouped view of androgen status (total and free testosterone), estrogen balance, pituitary signaling, blood counts, metabolic and liver/kidney function, cholesterol, and prostate screening markers—so dosing and risk checks can be discussed with the right context.
Do I need this panel?
You may benefit from this lab panel if you have symptoms that could fit low testosterone or hormone imbalance—such as low libido, erectile changes, reduced morning erections, fatigue, depressed mood, loss of strength, increased body fat, or slower recovery—and you want objective data before making treatment decisions.
This panel is also a practical fit if you are already on TRT/HRT and want to confirm that your therapy is effective while monitoring the common “watch-outs” that can change over time, including elevated hematocrit (thicker blood), shifts in cholesterol, liver enzyme changes, and prostate markers.
It can be especially helpful when you feel “off” despite being on therapy. In that situation, patterns across the panel (for example, high total testosterone but low free testosterone due to high SHBG, or symptoms with normal testosterone but abnormal thyroid or prolactin) often explain more than any single result.
Your results are meant to support clinician-directed care and shared decision-making, not self-diagnosis or self-prescribing.
Reference ranges and units vary by lab, and “free testosterone” may be measured directly or calculated from total testosterone, SHBG, and albumin; interpretation should consider the method used.
Lab testing
Order the Hormone Replacement Therapy (HRT) for Men Comprehensive panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault lets you order a comprehensive men’s HRT monitoring lab panel so you can see hormone effectiveness and safety markers together from a single blood draw. This is useful whether you are evaluating symptoms, establishing a baseline before starting therapy, or checking interval labs after a dose or protocol change.
After you receive results, you can use PocketMD to review your panel in plain language and in context—especially when multiple markers move together (for example, testosterone rising alongside hematocrit, or estradiol shifting with changes in body fat, dosing frequency, or aromatase inhibitor use).
If you are on TRT, the goal is usually not “the highest testosterone number.” It is a stable, symptom-aligned hormone profile with acceptable safety markers over time. This panel is built to support that kind of therapy-aware conversation and to make retesting straightforward when you and your clinician decide it is time.
- One order covers multiple hormone and safety markers commonly used for TRT/HRT monitoring
- Designed for trending over time (baseline → follow-up → maintenance checks)
- PocketMD can help you connect symptoms, dosing timing, and lab patterns
Key benefits of Hormone Replacement Therapy (HRT) for Men Comprehensive
- Clarifies androgen status by pairing total testosterone with free/bioavailable context (SHBG and albumin).
- Checks estrogen balance (estradiol) so symptoms like water retention, mood changes, or nipple tenderness are interpreted with labs—not guesswork.
- Screens pituitary signaling (LH/FSH and prolactin) to help distinguish primary testicular issues from central causes when appropriate.
- Monitors red blood cell changes (hemoglobin/hematocrit) that can rise on TRT and influence safety decisions.
- Tracks metabolic and organ-function markers (kidney, liver, glucose) that matter for long-term therapy planning.
- Assesses cardiovascular risk signals through a lipid panel, which can shift with hormones, weight change, and lifestyle.
- Includes prostate screening context (PSA) so you can discuss prostate health and TRT monitoring with clearer data.
What is the Hormone Replacement Therapy (HRT) for Men Comprehensive panel?
The Hormone Replacement Therapy (HRT) for Men Comprehensive panel is a bundled set of blood tests that evaluates male sex hormones and the body systems most commonly monitored when you are considering testosterone replacement therapy (TRT) or actively using it.
Rather than ordering one testosterone test in isolation, this panel looks at how testosterone is produced, transported, and converted—and whether therapy is affecting other systems. Testosterone in your blood exists in different forms: some is bound tightly to sex hormone–binding globulin (SHBG), some is loosely bound to albumin, and a small fraction is “free.” Because symptoms often track more closely with free or bioavailable testosterone than total testosterone alone, SHBG and albumin can change what a “normal” total testosterone means for you.
The panel also includes estradiol (E2), a key estrogen in men. Estradiol is not just a “side effect” hormone; it supports bone health, sexual function, and mood. On TRT, estradiol can rise due to aromatization (conversion of testosterone to estradiol), and both low and high estradiol patterns can be associated with symptoms.
Finally, the panel includes safety and monitoring markers that help you and your clinician evaluate risk and adjust a plan: complete blood count (CBC) for hematocrit/hemoglobin, a comprehensive metabolic panel (CMP) for liver and kidney function, a lipid panel for cholesterol patterns, and prostate-specific antigen (PSA) for prostate screening context. Taken together, these results help you move from “one number” to a more complete picture of efficacy, side effects, and overall health.
What do my panel results mean?
Patterns that can look “low” on this panel
A “low” pattern is often more than a low total testosterone result. You might see low total testosterone with low free testosterone, sometimes alongside higher LH/FSH (suggesting the testes are not responding well) or low/normal LH/FSH (suggesting a more central/pituitary signaling pattern). Low free testosterone with a normal total testosterone can happen when SHBG is high, which reduces the free fraction. In men on TRT, a “low” pattern can also reflect timing (labs drawn too long after an injection or missed doses), under-dosing, absorption issues with topical therapy, or inconsistent administration. If symptoms persist while testosterone markers look adequate, other parts of the panel—thyroid-adjacent signals, anemia patterns on CBC, elevated prolactin, or metabolic markers—may point to non-testosterone contributors.
Patterns that are often considered “optimal” for monitoring
An “optimal” pattern usually means your testosterone markers are in a range that matches your goals and symptoms while safety markers remain acceptable. That often looks like total and free testosterone that are consistent with your dosing schedule, estradiol that is not excessively suppressed or disproportionately high relative to testosterone, and stable CBC values without a rising hematocrit trend. On the metabolic side, liver enzymes, kidney markers, fasting glucose (or A1c if included), and lipids are steady or improving with lifestyle changes. PSA is best interpreted as a trend over time rather than a single data point; stability is generally reassuring, especially when matched to age, prostate history, and clinical context.
Patterns that can look “high” and why they matter
A “high” pattern may include supraphysiologic testosterone (especially if labs are drawn near a post-injection peak), elevated estradiol, and/or rising hematocrit and hemoglobin. High hematocrit is one of the most important TRT monitoring signals because it can increase blood viscosity and may change your clinician’s risk assessment or dosing plan. You may also see lipid shifts (for example, HDL dropping or LDL rising) depending on genetics, diet, body composition changes, and the type of therapy. PSA can rise for reasons other than cancer—such as benign prostatic enlargement, inflammation, recent ejaculation, cycling, or urinary symptoms—but a notable rise or upward trend deserves a clinician-guided follow-up plan rather than reassurance based on a single number.
Factors that influence your panel results
Timing and preparation can change how your panel reads. Testosterone varies by time of day and by dosing schedule; injections can create peaks and troughs, while gels may be more steady but depend on absorption and application technique. SHBG is influenced by age, thyroid status, liver health, calorie balance, and certain medications, and it can make total testosterone look “better” or “worse” than your free testosterone suggests. Estradiol is influenced by body fat, alcohol intake, dosing amount and frequency, and aromatase inhibitor use (which can push estradiol too low in some men). CBC markers shift with hydration status, sleep apnea, smoking, altitude, and testosterone dose. PSA is affected by age, prostate size, inflammation, recent ejaculation, vigorous cycling, and some medications; it is best interpreted as a trend and in context of symptoms and exam history.
Biomarkers included in this panel
- Absolute Band Neutrophils
- Absolute Basophils
- Absolute Blasts
- Absolute Eosinophils
- Absolute Lymphocytes
- Absolute Metamyelocytes
- Absolute Monocytes
- Absolute Myelocytes
- Absolute Neutrophils
- Absolute Nucleated Rbc
- Absolute Plasma Cells
- Absolute Prolymphocytes
- Absolute Promyelocytes
- Absolute Reactive Lymphocytes
- Albumin
- Albumin/Globulin Ratio
- Alkaline Phosphatase
- Alt
- Ast
- Band Neutrophils
- Basophils
- Bilirubin, Total
- Blasts
- Bun/Creatinine Ratio
- Calcium
- Carbon Dioxide
- Chloride
- Creatinine
- Dhea Sulfate
- Dihydrotestosterone
- Egfr
- Eosinophils
- Estradiol
- Fsh
- Globulin
- Glucose
- Hematocrit
- Hemoglobin
- Igf 1, Lc/Ms
- Lh
- Lymphocytes
- Mch
- Mchc
- Mcv
- Metamyelocytes
- Monocytes
- Mpv
- Myelocytes
- Neutrophils
- Nucleated Rbc
- Plasma Cells
- Platelet Count
- Potassium
- Pregnenolone, Lc/Ms
- Prolactin
- Prolymphocytes
- Promyelocytes
- Protein, Total
- Rdw
- Reactive Lymphocytes
- Red Blood Cell Count
- Sex Hormone Binding Globulin
- Sodium
- Testosterone, Free
- Testosterone, Total, Ms
- Urea Nitrogen (Bun)
- White Blood Cell Count
- Z Score (Female)
- Z Score (Male)
Frequently Asked Questions
Do I need to fast for this HRT monitoring panel?
Fasting is often recommended if your panel includes a lipid panel and glucose, because recent meals can raise triglycerides and affect calculated LDL. If you cannot fast, you can still test, but tell your clinician and note whether you were fasting so results are interpreted appropriately.
When should you draw labs if you are on testosterone injections?
Timing depends on your dosing schedule and what you are trying to evaluate (peak vs trough). Many clinicians prefer a consistent “mid-interval” or trough-style draw to compare trends over time, but protocols vary. The key is consistency: draw at the same point in your dosing cycle each time and document your last dose date/time.
Why does this panel include SHBG and albumin instead of only total testosterone?
Total testosterone does not tell you how much hormone is available to tissues. SHBG and albumin influence the free and bioavailable fractions. Two men can have the same total testosterone but very different free testosterone depending on SHBG, which is why these markers help explain symptoms and guide dosing discussions.
What does a rising hematocrit mean on TRT?
TRT can stimulate red blood cell production, which may raise hemoglobin and hematocrit. A rising trend can change your risk assessment and may lead to dose adjustments, evaluation for contributing factors (like sleep apnea or dehydration), or other clinician-directed steps. Do not self-manage based on one value—trend and context matter.
Should you worry if PSA is higher than your last test?
PSA can fluctuate for benign reasons, and a single elevated value is not a diagnosis. What matters is the overall level, the rate of change over time, your age, prostate history, urinary symptoms, and exam findings. If PSA rises meaningfully or continues trending up, follow up with your clinician for repeat testing and next-step evaluation.
How is this panel different from ordering testosterone and estradiol alone?
Single tests can miss the context that changes decisions. This panel combines hormone effectiveness markers with common safety and monitoring labs (CBC, CMP, lipids, PSA) so you can evaluate benefits and tradeoffs together, especially when adjusting dose, frequency, or delivery method.
Can this panel help if you want to preserve fertility while addressing low testosterone symptoms?
It can provide useful baseline information (testosterone, LH/FSH, prolactin) that helps frame a fertility-aware discussion, because TRT can suppress LH/FSH and reduce sperm production in many men. Fertility planning usually requires additional evaluation (such as semen analysis) and a clinician-guided strategy tailored to your goals.